WO2000076968A1 - Process for the synthesis of a-nor-seco compounds with sterane skeleton - Google Patents
Process for the synthesis of a-nor-seco compounds with sterane skeleton Download PDFInfo
- Publication number
- WO2000076968A1 WO2000076968A1 PCT/HU2000/000047 HU0000047W WO0076968A1 WO 2000076968 A1 WO2000076968 A1 WO 2000076968A1 HU 0000047 W HU0000047 W HU 0000047W WO 0076968 A1 WO0076968 A1 WO 0076968A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- androstane
- methyl
- hydroxy
- seco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC(CC*)(CC(*)(CC1)CC2C3=O)C1(*)CC2NC3=CC Chemical compound CC(CC*)(CC(*)(CC1)CC2C3=O)C1(*)CC2NC3=CC 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
- C07C51/285—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation with peroxy-compounds
Definitions
- the invention relates to a new process for the synthesis of 17 ⁇ -hydroxy-17 ⁇ -methyl- l,3-seco-2-nor-5 -androstane-3-acid derivatives of formula (1)
- R 1 and R 2 independently are C ⁇ -C alkyl or alkoxy group, hydrogen or halogen atom - which are intermediates for preparing the compounds of formula (I).
- the 17 ⁇ -hydroxy-17 ⁇ -methyl-l,3-seco-2-nor-5 ⁇ -androstane-3-acid derivatives of formula (I) are intermediates in the synthesis of oxandrolon (17 ⁇ -hydroxy-17 ⁇ -methyl-2-oxa- 5 ⁇ -androstane-3-one), which is used as anabolic in therapy.
- the oxandrolone is used in pediatrics and for mitigation of loss of weight developing as a consequence of infections, traumas and surgical intervention. Recently the therapeutic use was extended to the improvement of the condition of AIDS patients.
- the reaction of mestanolone of formula (III) and aromatic nitro-aldehyde of formula (IV) is preferably carried out in methanol as C 1 -C4 alcohol in the presence of potassium hydroxide.
- the mestanolone is preferably suspended in the mixture of the alcohol type solvent and the aqueous alkali metal hydroxide and the aromatic nitro-aldehyde of formula (IV) in alcoholic solution is added to the reaction.
- the addition can be carried out between 0°C and the reflux temperature of the reaction mixture. The completion time of the reaction depends on the temperature.
- the pH is checked and in case of deviation it is adjusted to the required value by addition of further alkali metal hydroxide solution.
- the precipitated manganese dioxide is filtered off or is dissolved with the addition of a reductive agent, i.e. sodium sulfite. - 5 -
- the pH of the solution is adjusted to 5.5-6.5 and concentrated.
- the possible impurities precipitated from the concentrated solution are filtered off, the pH of the filtrate (which contains the desired product) is adjusted to 0-2.5 with addition of acid.
- the precipitated product is filtered off, washed with water and dried.
- the crude product is purified by suspending and stirring it in a halogenated alkan or in a mixture of a halogenated alkan and a ketone or in a ketone type solvent and subsequent filtration or recrystallization from a ketone type solvent.
- the reaction is carried out the same way as in the synthesis of 17 ⁇ -hydroxy-17 ⁇ -methyl-l,3-seco-2-nor-5 ⁇ -androstane-3-acid derivative of formula (I), wherein Z is carboxyl group, with the difference that the temperature of the oxidation is 15-30°C instead of 15-40°C and 1-1.5 mol equivalent of alkali metal permanganate is used instead of 2.5-5 mol equivalent.
- the crude product is purified by recrystallization from acetonitrile or from a ketone type solvent.
- the oxidative cleavage of the C ⁇ - double bond of secoindoxylidene carboxylic acid derivatives of formula (II) is preferably carried out in acetone, ethanol or tertiary-butanol using sodium hydroxide as base. Both oxidation reactions are preferably carried out at 20-30°C.
- Example 6 17 ⁇ -Hvdroxy-17 ⁇ -methyl-13-seco-2-nor-5 ⁇ -androstane-1.3-diacid 5 g (1 1.4 mmol) of crude 17 ⁇ -hydroxy-17 ⁇ -methyl-l-(1.3-dihydro-3-oxo-2H-indol-2- ylidene)-l,3-seco-2-nor-5 ⁇ -androstane-3-acid, obtained in Example 2, is dissolved in 40 cm of acetone and 0.8 g (20 mmol) of sodium hydroxide in 40 cm J of water is added. 5.4 g (34.2 mmol.
- the filtrate is neutralized with 520 cm of 10% sulfuric acid is (pH ⁇ 6- 7), then the tertiary-butanol is evaporated at diminished pressure.
- the residue is cooled to 18- 20°C and after 20 min stirring the precipitated crystals (the by-products of the previous and the present reaction) are filtered off and washed with 200 cm of water.
- the filtrate is acidified with 1300 cm J of 10%) sulfuric acid (pH ⁇ 2) at 20-25°C.
- the crystalline solution is stirred for 15 min. then filtered, washed with water and dried at 50°C till the weight is constant to yield 301 g (83.0%) of crude title compound.
- Mp 176-190°C.
- reaction mixture is filtered and the manganese dioxide is washed with 4.0 dm 3 of a 1 :3 mixture of tertiary-butanol-water.
- the residue is cooled to 18-20°C and after 20 min stirring the precipitated crystals (the by-products of the previous and the present reaction) are filtered off and washed with 200 cm of water.
- the crystalline solution is stirred for 15 min, then filtered, washed with water and dried at 50°C till the weight is constant to yield 359 g (99.0%) of crude title compound.
- Mp 178-190°C.
- Example 7 25 g of the crude product obtained in Example 7 is dissolved in 530 cm of acetone at reflux temperature, treated with 1.0 g of charcoal, filtered, then the filtrate is concentrated to a volume of 60 cm 3 . The concentrated mixture is cooled to 10°C and kept at this temperature for 2 h, then the precipitated crystalline product is filtered off. washed with 20 cm of cold acetone and dried to yield 20.1 g (80.4%) of the title compound. Mp: 248-250°C.
- Example 11 17 ⁇ -Hvdro ⁇ y-17 ⁇ -methyl-l,3-seco-2-nor-5 ⁇ -androstane-l,3-diacid 3 g (6.4 mmol) of 17 ⁇ -hydroxy-17 ⁇ -methyl-l-(5-chloro-l,3-dihydro-3-oxo-2H-indol-2- ylidene)-l,3-seco-2-nor-5 ⁇ -androstane-3-acid, obtained in Example 3. is added to a stirred mixture of 0.5 g (12.5 mmol) of sodium hydroxide in 20 cm of water and 50 cm of tertiary- butanol.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Steroid Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Description
Claims
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU52395/00A AU5239500A (en) | 1999-06-10 | 2000-05-26 | Process for the synthesis of a-nor-seco compounds with sterane skeleton |
| EP00937109A EP1189885B1 (en) | 1999-06-10 | 2000-05-26 | Process for the synthesis of a-nor-seco compounds with sterane skeleton |
| US10/030,743 US6448413B1 (en) | 1999-06-10 | 2000-05-26 | Process for the synthesis of a-nor-seco compounds with sterane skeleton |
| AT00937109T ATE246175T1 (en) | 1999-06-10 | 2000-05-26 | METHOD FOR PRODUCING A-NOR-SECO COMPOUNDS WITH STERAN SKELETON |
| DE60004230T DE60004230T2 (en) | 1999-06-10 | 2000-05-26 | METHOD FOR PRODUCING A-NOR-SECO CONNECTIONS WITH STERANE SKELETON |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP9901939 | 1999-06-10 | ||
| HU9901939A HU224816B1 (en) | 1999-06-10 | 1999-06-10 | Process for producing a-nor-seco-steroide compounds, seco-indoxylidenecarboxilicacid derivetives as intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2000076968A1 true WO2000076968A1 (en) | 2000-12-21 |
Family
ID=89998479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/HU2000/000047 Ceased WO2000076968A1 (en) | 1999-06-10 | 2000-05-26 | Process for the synthesis of a-nor-seco compounds with sterane skeleton |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6448413B1 (en) |
| EP (1) | EP1189885B1 (en) |
| AT (1) | ATE246175T1 (en) |
| AU (1) | AU5239500A (en) |
| DE (1) | DE60004230T2 (en) |
| ES (1) | ES2203483T3 (en) |
| HU (1) | HU224816B1 (en) |
| WO (1) | WO2000076968A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6820256B2 (en) * | 2000-12-13 | 2004-11-16 | Microsoft Corporation | System and method for whole-system program analysis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128283A (en) * | 1961-05-10 | 1964-04-07 | Searle & Co | 17-oxygenated oxa-steroids and intermediates thereto |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3280133A (en) * | 1964-10-12 | 1966-10-18 | Searle & Co | (optionally alkylated)-2-aza-5alpha-androstan-17beta-ols and acyl derivatives thereof |
-
1999
- 1999-06-10 HU HU9901939A patent/HU224816B1/en unknown
-
2000
- 2000-05-26 DE DE60004230T patent/DE60004230T2/en not_active Expired - Lifetime
- 2000-05-26 EP EP00937109A patent/EP1189885B1/en not_active Expired - Lifetime
- 2000-05-26 US US10/030,743 patent/US6448413B1/en not_active Expired - Fee Related
- 2000-05-26 WO PCT/HU2000/000047 patent/WO2000076968A1/en not_active Ceased
- 2000-05-26 AU AU52395/00A patent/AU5239500A/en not_active Abandoned
- 2000-05-26 ES ES00937109T patent/ES2203483T3/en not_active Expired - Lifetime
- 2000-05-26 AT AT00937109T patent/ATE246175T1/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3128283A (en) * | 1961-05-10 | 1964-04-07 | Searle & Co | 17-oxygenated oxa-steroids and intermediates thereto |
Non-Patent Citations (3)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 117, no. 3, 20 July 1992, Columbus, Ohio, US; abstract no. 20715z, BI, HONGGANG ET AL.: "Studies on anabolic steroids-8. GC/MS characterization of unusual seco acidic metabolites of oxymetholone in human urine." XP002149884 * |
| DATABASE CHEMICAL ABSTRACTS XP002149885 * |
| J. STEROID BIOCHEM. MOL. BIOCHEM., vol. 42, no. 2, - 1992, pages 229 - 242 * |
Also Published As
| Publication number | Publication date |
|---|---|
| HU224816B1 (en) | 2006-02-28 |
| DE60004230T2 (en) | 2004-05-27 |
| AU5239500A (en) | 2001-01-02 |
| ES2203483T3 (en) | 2004-04-16 |
| EP1189885B1 (en) | 2003-07-30 |
| US6448413B1 (en) | 2002-09-10 |
| DE60004230D1 (en) | 2003-09-04 |
| ATE246175T1 (en) | 2003-08-15 |
| EP1189885A1 (en) | 2002-03-27 |
| HU9901939D0 (en) | 1999-08-30 |
| HUP9901939A2 (en) | 2001-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1161848A (en) | Substituted indoline-2-one derivatives | |
| US4316020A (en) | Preparation of isatoic anhydrides | |
| US4978773A (en) | Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives | |
| EP1189885B1 (en) | Process for the synthesis of a-nor-seco compounds with sterane skeleton | |
| US4313000A (en) | Process for preparing 5-(2-chloro-4-trifluoromethylphenoxy)-2-nitro-N-alkanesulphonyl benzamides from a toluene derivative and intermediates | |
| HU185378B (en) | Process for producing 7-alkoxy-carbonyl-6,8-dimethyl-4-hydroxy-methyl-1-phtalazones | |
| CN101815709B (en) | The manufacture method of dibenzo oxa-* compound | |
| EP1189925B1 (en) | New process for the synthesis of 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androstane-3-one | |
| US6384217B1 (en) | 5-cyano-10-hydroxy-10,11-dihydro-5h-dibenz[b,f]azepine, the processes for its preparation and for its conversion into 5-carbamoyl-10-oxo-10, 11-dihydro-5h-dibenz[b,f]azepine or into 5-carbamoyl-5h-dibenz[b,f]azepine | |
| SU1124886A3 (en) | Method of obtaining quinolines | |
| JPH09268186A (en) | Method for producing 4-chromanones | |
| NO309600B1 (en) | Improved process for the preparation of 4-hydroxy-2-pyrrolidone | |
| HU196381B (en) | Process for preparing 8-halogen-5,6-dialkoxy-quinazolin-2,4-dione derivatives | |
| EP0052959B1 (en) | Production of purine derivatives and intermediates therefor | |
| US4751314A (en) | Preparation of tetrachloro-3-iminoisoindolin-1-one | |
| SU262906A1 (en) | METHOD OF OBTAINING INDOL PRODUCTION | |
| JP3976286B2 (en) | Method for producing 2-benzoyl-cyclic 1,3-diketone derivative | |
| US4024136A (en) | Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide | |
| US3347864A (en) | Production of aminoquinolines | |
| US5124459A (en) | Process for the preparation of 3-(3-pyridyl)-1H,3H-pyrrolo[1,2-c]thiazole-7-carbonitrile | |
| CZ291601B6 (en) | Process for preparing formyl imidazoles | |
| JP4075342B2 (en) | Process for producing 4,5-disubstituted-1,2,3-triazole | |
| PL123691B1 (en) | Process for preparing derivatives of pyrimido/1,2-a/azepines | |
| EP0359474A1 (en) | Pyridazinone manufacture | |
| KR800000408B1 (en) | Method for producing 4-hydroxy-2H-naphtho [2, 1-e] -1, 2-thiazine-3-carboxamide-1, 1-dioxides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 10030743 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2000937109 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2000937109 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWG | Wipo information: grant in national office |
Ref document number: 2000937109 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |









